Early drotrecogin alpha (activated) administration in severe sepsis is associated with lower mortality: a retrospective analysis of the Canadian ENHANCE cohort

INTRODUCTION: Early multimodal treatment of severe sepsis, including the use of drotrecogin alfa (activated) (DrotAA) when indicated, is considered essential for optimum outcome. However, predicting which infected patients will progress to severe sepsis and the need for aggressive intervention conti...

Descripción completa

Detalles Bibliográficos
Autores principales: Hodder, Richard V, Hall, Richard, Russell, James A, Fisher, Harold N, Lee, Bobbie
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717441/
https://www.ncbi.nlm.nih.gov/pubmed/19457240
http://dx.doi.org/10.1186/cc7893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717441/
https://www.ncbi.nlm.nih.gov/pubmed/19457240
http://dx.doi.org/10.1186/cc7893

Ejemplares similares